Hematoporphyrin Photomedicine of Cancer

  • Michael W. Berns


The concentration of porphyrins by malignant tissue has been known for decades and has been thoroughly reviewed in several recent symposium volumes.1–3 From these symposia as well as the many articles published in refereed journals, a picture emerges that is both positive and negative. On the positive side it has been demonstrated that (1) some porphyrins are concentrated selectively in malignant tumors in animals and man; (2) the concentrated porphyrins can be detected by fluorescence emission, thus facilitating identification of malignancy; (3) the concentrated porphyrins will absorb light of particular wavelengths, leading to a photochemical destruction of the tumor; and (4) in some human cases, localized tumors have been eradicated by this method with no regrowth detected for up to 2 years.


Tumor Destruction Hematoporphyrin Derivative Concentrate Porphyrin Photoradiation Therapy Complete Response Partial Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kessel D, Dougherty TJ (eds): Advances in Experimental Medicine and Biology, Vol. 160: Porphyrin Photosensitization. Plenum Press, New York.Google Scholar
  2. 2.
    Berns M: Laser Surg Med 4, 1984.Google Scholar
  3. 3.
    Doiron D, Gomer CJ (eds): Prog Clin BioI Res 170, 1984.Google Scholar
  4. 4.
    Moan I, Christensen T, Sommer S: The main photosensitizing components of hematoporphyrin derivative. Cancer Lett 55:161–166, 1982.CrossRefGoogle Scholar
  5. 5.
    Berenbaum M, Bonnett R, Scourides PA: In vivo biological activity of the components of hematoporphyrin derivative. Br J Cancer 45:571–581, 1982.CrossRefGoogle Scholar
  6. 6.
    Dougherty TJ: An overview of the status of photoradiation therapy. In: Progress in Clinical Biological Research, Vol. 170: Porphyrin Localization and Treatment of Tumors, pp. 75–87. Alan R. Liss, New York, 1984.Google Scholar
  7. 7.
    Berns MW, Hammer-Wilson M, Walter RJ, et al.: Uptake and localization of HpD and “active fraction” in tissue culture and in serially biopsied human tumors.Prog Clin BioI Res 170:501–520, 1984.Google Scholar
  8. 8.
    Kessel D: Chemical and biochemical determinants of porphyrin localization. Prog Clin Biol Res 170:405–418, 1984.Google Scholar
  9. 9.
    Gibson SL, Leakey PB, Crute JJ, Hilf R: Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative (HpD) in vitro and in vivo. Prog Clin Biol Res 170:323–334, 1984.Google Scholar
  10. 10.
    Bonnett R, Berenbaum M, Scourides PA: In vivo biological activity of the components of hematoporphyrin derivative (HpD). Br J Cancer 45:571–581, 1982.CrossRefGoogle Scholar
  11. 11.
    Evensen J, Sommer S, Moan J, Christensen T: Tumor localizing and photosensitizing properties of main components of hematoporphyrin derivative. Cancer Res 44:482–486, 1984.Google Scholar
  12. 12.
    Moan J, Christensen T, Jacobsen PB: Porphyrin-sensitized photoinactivation of cells in vitro. Prog Clin Biol Res 170:419–442, 1984.Google Scholar
  13. 13.
    Dougherty TJ, Boyle DG, Weishaupt KR, et al.: Photoradiation: clinical and drug advances. In: Advances in Experimental Medicine and Biology, Vol. 160:Porphyrin Plotosensitization, pp. 3–13. Plenum Press, New York, 1983.Google Scholar
  14. 14.
    Benson RC, Farrow GM, Kinsey IH, et al.: Detection and localization of in situ carcinoma of the blader with hematoporphyrin derivative. Mayo Clin Proc 57:548–555, 1982.Google Scholar
  15. 15.
    Balchum OJ, Doiron DR, Huth GC: Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphyrin erivative. Lasers Surg Med 4:13–30, 1984.CrossRefGoogle Scholar
  16. 16.
    Kato H, Aizawa K, Ono J, et al.: Clinical measurement of tumor fluorescence using a new diagnostic system with hematoporphyrin derivative, laser photoradiation, and a spectroscope. Lasers Surg Med 4:49–58, 1984.CrossRefGoogle Scholar
  17. 17.
    Boggan JE, Walter RJ, Edwards MSB, et al.: Distribution of HpD in the rat 9L gliosarcoma brain tumor as analyzed by digital video fluorescence microscopy.J Neurosurg 61:1113–1119, 1984.CrossRefGoogle Scholar
  18. 18.
    Grossweiner LI: Membrane photosensitization by hematoporphyrin and hematoporphyrin derivative. Prog Clin Biol Res 170:391–404, 1984.Google Scholar
  19. 19.
    Nelson JS, Wright WH, Berns MW: Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer enhanced digital video fluorescence microscopy. Cancer Res 45:5781–5786, 1985.Google Scholar
  20. 20.
    Weishaupt KR, Gomer CJ, Dougherty TJ: Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36:2326–2329, 1976.Google Scholar
  21. 21.
    Berns MW, Dahlman A, Johnson FM, et a1.: In vitro cellular effects of hematoporphyrin derivative (HpD). Cancer Res 42:2325–2329, 1982.Google Scholar
  22. 22.
    Salet C, Moreno G: Photodynamic effects of hematoporphyrin derivative (HpD) on respiration and calcium uptake in isolated mitochondria. Int J Radiat Biol 39:96–100, 1979.Google Scholar
  23. 23.
    Torinuki W, Miiura T, Seiji M: Lysosome destruction and lipoperoxide formation due to active oxygen generated from hematoporphyrin and uv irradiation. Br J Dermatol 102:17–27, 1980.CrossRefGoogle Scholar
  24. 24.
    Bugelski PJ, Porter CW, Dougherty TJ: Autoradiographic distribution of hernatoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res 41:4606–4612, 1981.Google Scholar
  25. 25.
    Henderson BW, Dougherty TJ, Malone PB: Studies on the mechanism of tumor destruction by photoradiation therapy. Prog Clin Biol Res 170:601–612, 1984.Google Scholar
  26. 26.
    Star WM, Marijnissen JPA, van den Berg-Blok AE, Reinhold HS: Destructive effect of photoradiation on the microcirculation of a rat mammary tumor growing in “sandwich” observation chambers. Prog Clin Biol Res 170:637–645, 1984.Google Scholar
  27. 27.
    Dahlman A, Wile AG, Burns RG, et al.: Laser photoradiation therapy of cancer.Cancer Res 43:430–434, 1982.Google Scholar
  28. 28.
    Li J-H, Chen Y-P, Chen ZS-D, Zhang L-T, Song S-Z: Application of hematoporphyrin derivative and laser-induced photodynamical reaction in the treatment of lung cancer: a preliminary report on 21 cases. Lasers Surg Med 4:31–38, 1984.CrossRefGoogle Scholar
  29. 29.
    Hayata Y, Kato H, Konaka C, et al.: Hematoporphyrin derivative and photoradiation therapy in early stage lung cancer. Lasers Surg Med 4:39–48, 1984.CrossRefGoogle Scholar
  30. 30.
    Bruce RA: Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas. Lasers Surg Med 59–64, 1984.Google Scholar
  31. 31.
    Rettenmaier MA, Berman ML, DiSaia PJ, et a1.: Photoradiation therapy of gynecologic malignancies. Gynecol Oncol 17:200–206, 1984.CrossRefGoogle Scholar
  32. 32.
    Wile A, Novotny J, Mason GR, et al.: Photoradiation therapy of head and neck cancer. J Clin Oncol 6:39–43, 1984.Google Scholar
  33. 33.
    McCulloch GAJ, Forbes IJ, See KL, et a1.: Phototherapy in malignant brain tumors. Prog Clin Biol Res 170:709–717, 1984.Google Scholar
  34. 34.
    Tsuchiya A, Obara N, Makoto M, et al.: Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. J Urol 130:7982, 1983.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1987

Authors and Affiliations

  • Michael W. Berns

There are no affiliations available

Personalised recommendations